
FDA approves new blood test for colon cancer screening: ‘Early detection is critical’
Fox News
The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.
Shield, made by Guardant Health in California, is the first approved blood test that is considered a primary screening option for the disease and meets Medicare coverage requirements, the company stated. "Compared to colonoscopy, it is simpler and less time-consuming." The test is expected to be commercially available by this fall. Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
The FDA’s approval, announced Tuesday, follows a large clinical trial that included 20,000 average-risk adults, which found that Shield had an 83% sensitivity for the detection of CRC.













